Choosing Medicare Advantage at 65 can feel like a one-way door. The plans are cheaper up front than pairing Original Medicare with a supplement, but retirees often worry that if the network or the drug list disappoints, they will be stuck, unable to buy a Medigap policy later without passing a health review that could price them out or turn them down. A little-known rule closes that trap, at least once: a first-year trial right that lets a new enrollee reverse course and buy a supplement on guaranteed terms.
The trial right, in plain terms
The trial right applies to people who sign up for a Medicare Advantage plan when they first become eligible for Medicare at 65. If, within the first 12 months, the plan turns out to be a poor fit, the enrollee can drop it, return to Original Medicare, and buy a Medicare Supplement policy, known as Medigap, with a guaranteed right to coverage. A parallel version protects someone who dropped a Medigap policy to try Advantage for the first time and wants that same policy back within a year. Either way, the escape hatch exists for a limited window and then closes.
The value hinges on two words: guaranteed issue. According to Medicare’s guidance on when to buy a Medigap policy, the strongest protections apply during specific windows when an insurer must sell a policy regardless of health history. During a trial right, the insurer cannot use medical underwriting to deny coverage, charge more because of a preexisting condition, or impose a waiting period. Outside those windows, in most states, a Medigap insurer is free to review an applicant’s health and say no.
Free for readers: Social Security and Medicare change every year, and nobody sends a memo. The free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
Why a health review is the whole game
Medigap matters because Original Medicare, on its own, leaves an open-ended gap. After the deductible, Part B generally pays 80 percent of covered costs and the beneficiary owes the other 20 percent, with no annual limit on that share. A supplement is what caps that exposure. But supplements are medically underwritten in most states once the initial protections lapse, so a retiree who develops a serious condition after choosing Advantage could find that the safety net is no longer for sale at any reasonable price. The trial right preserves access to that net during the first year, before health history can be held against an applicant.
The stakes rise with age and health. A 66-year-old in good health who picks Advantage and later wants a supplement might still qualify through underwriting in some states, but the same person at 75, after a cardiac event or a cancer diagnosis, could be declined outright or quoted a premium that makes the policy pointless. Guaranteed issue removes that gamble for the length of the trial right. It is the one stretch when the decision to test Advantage can be reversed without an insurer weighing a medical file.
Getting the timing exactly right
The mechanics reward precision. The trial right runs 12 months from the start of Advantage coverage, and the guaranteed-issue Medigap right generally must be used as that Advantage coverage ends, within a tight window on either side. A beneficiary weighing the move can compare what Original Medicare plus a supplement would cost against the Advantage plan’s structure before the clock runs out. Missing the window does not necessarily bar a supplement forever, but it usually means facing underwriting, where approval and price depend on health rather than on a guarantee.
It also helps to know what the trial right is not. It does not guarantee the cheapest supplement, only the right to buy one without a health screen; premiums still vary by insurer, plan letter and location, so comparison shopping matters even under a guarantee. And it does not last indefinitely. Once the 12 months pass, the same purchase usually becomes subject to underwriting again. The protection is generous but time-boxed, which is exactly why the deadline deserves a place on the calendar the day Advantage coverage starts.
How the switch back works in practice
Reversing the choice is a sequence, not a single step. The enrollee first arranges to leave the Advantage plan and return to Original Medicare, then applies for a Medigap policy while the guaranteed-issue right is active, and, if wanted, adds a standalone Part D drug plan, since Original Medicare does not include drug coverage. Because a lapse in one piece can leave a gap in another, the steps are best lined up before the trial-right deadline rather than after. A short call to a State Health Insurance Assistance Program, which offers free counseling, can help a retiree sequence the moves without a coverage gap.
What it means for a first-year enrollee
The practical takeaway is that trying Medicare Advantage in the first year is less risky than it looks, provided the calendar is respected. A retiree who signs up, watches how the plan performs, and tracks the 12-month deadline keeps the option to switch back to Original Medicare and add a guaranteed supplement. Comparing available Medigap policies before the deadline turns the trial right from a technicality into a real second chance.
The rule rewards whoever knows it
Most of the money at stake here is invisible until something goes wrong. A trial right used in time can be the difference between a capped, predictable supplement premium and an uncapped 20 percent share on a major illness that no insurer will now cover. The rule quietly rewards the enrollee who knows it exists and acts inside the window, and penalizes the one who assumes the first choice is permanent. A retiree does not need to master every plan rule to use the trial right; noting a single date and a single option is enough to keep a costly door from locking. For anyone testing Advantage in year one, that deadline is worth writing on the calendar the day coverage begins, alongside a note of what it protects.
Free for readers: Miss an enrollment or claim deadline and it’s gone. The free Retirement Shield newsletter keeps readers ahead of the ones that matter. Get the free newsletter.
This article was researched and drafted with AI assistance and reviewed against the linked primary sources.
David M. Keller is a finance writer based in Columbus, Ohio, covering personal finance and consumer-focused economic topics. He earned his degree in journalism from Ohio University and began his career reporting on local business and economic trends for a regional media outlet. Since then, he has contributed to a variety of online publications, focusing on clear, practical coverage of topics such as cost of living, debt, and everyday financial decision-making.
